Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

1.58
Delayed Data
As of Jul 01
 +0.09 / +6.04%
Today’s Change
1.23
Today|||52-Week Range
20.45
-84.36%
Year-to-Date
No recent news for Aegerion Pharmaceuticals Inc.

Today’s Trading

Previous close1.49
Today’s open1.49
Day’s range1.44 - 1.62
Volume459,378
Average volume (3 months)957,891
Market cap$44.0M
Dividend yield--
Data as of 4:00pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)-88.89%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.84%
Revenue growth (last year)+51.47%
P/E ratioNM
Price/Sales1.21
Price/Book0.38

Competitors

 Today’s
change
Today’s
% change
PZRXPhaseRx Inc-0.05-1.20%
VSTMVerastem Inc+0.06+4.62%
FATEFate Therapeutics In...+0.13+7.65%
CANFCan Fite Biopharma L...+0.07+2.94%
Data as of 4:00pm ET, 07/01/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$239.9M
Annual profit (last year)-$73.3M
Net profit margin-30.57%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mary J. Szela
Chief Financial &
Administrative Officer
Gregory D. Perry
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs